Lilly has a new blockbuster
World of DTC Marketing
MAY 16, 2022
Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes. The drug led to impressive blood sugar and body weight drops in clinical trials. The approval for tirzepatide—which Lilly will market under the brand name Mounjaro—isn’t for weight loss but Type 2 diabetes. A matter of trust?
Let's personalize your content